Related references
Note: Only part of the references are listed.CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
Kenneth F. Schulz et al.
ANNALS OF INTERNAL MEDICINE (2010)
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA)
Don Poldermans et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2010)
MENU LABELING: KNOWLEDGE FOR A HEALTHIER AMERICA
Tamara Schulman
HARVARD JOURNAL ON LEGISLATION (2010)
Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Noncardiovascular Surgery A Randomized Controlled Trial (DECREASE-IV)
Martin Dunkelgrun et al.
ANNALS OF SURGERY (2009)
Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery.
Olaf Schouten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effects of extended-release metoprolol succinate inpatients undergoing non-cardiac surgery (POISE trial):: a randomised controlled trial
P. J. Devereaux et al.
LANCET (2008)
Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery
Harm H. H. Feringa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease
Marc S. Sabatine et al.
CIRCULATION (2007)
Review article: The role of statins in reducing perioperative cardiac risk: physiologic and clinical perspectives
Nader N. Boushra et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2006)
Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial
AES Durazzo et al.
JOURNAL OF VASCULAR SURGERY (2004)
Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: Outcomes and effects on length of stay
KE Fleischmann et al.
AMERICAN JOURNAL OF MEDICINE (2003)
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
S Kinlay et al.
CIRCULATION (2003)
Anti-inflammatory effect of Atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction
LCL Correia et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Relationship between effects of statins, aspirin and anglotensin II modulators on high-sensitive C-reactive protein levels
T Takeda et al.
ATHEROSCLEROSIS (2003)
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
PS Sever et al.
LANCET (2003)
The pathophysiology of perioperative myocardial infarction: Facts and perspectives
G Landesberg
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2003)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Inflammatory responses after surgery
S Herroeder et al.
HOSPITAL MEDICINE (2002)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
